No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study

Lancet

Volumn 351, Issue 9112, 1998, Pages 1327-1328

  Peltola, Heikki ^a   Patja, Annamari ^b   Leinikki, Pauli ^b   Valle, Martti ^b   Davidkin, Irja ^b   Paunio, Mikko ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; ENTERITIS; FEMALE; HUMAN; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0032474231     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)24018-9     Document Type: Article

References (4)

1. 1 Lee JW, Melgaard B, Clements CJ, et al. Autism, inflammatory bowel disease, and MMR vaccine. Lancet 1998; 351: 905-09.
2. 2 Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-41.
3. 3 Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994; 331: 1397-402.
4. 4 Tait DR, Ward KN, Brown DWG, Miller E. Measles and rubella misdiagnosed in infants as exanthem subitrum (roseola infantum). BMJ 1996; 312: 101-02.